Newly synthesized Mpro inhibitors as potential oral anti-SARS-CoV-2 agents

被引：0
|
作者：
Lin Li
Shile Huang
机构：
[1] Louisiana State University Health Sciences Center,Department of Biochemistry and Molecular Biology
[2] Louisiana State University Health Sciences Center,Department of Hematology and Oncology
[3] Louisiana State University Health Sciences Center,Feist
来源：
Signal Transduction and Targeted Therapy | / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Computational repurposing of asthma drugs as potential inhibitors of SARS-CoV-2 Mpro
    Hussain, A.
    NEW MICROBES AND NEW INFECTIONS, 2022, 47
  • [32] Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
    Soumya Gulab Katre
    Alpana Jagdish Asnani
    Kumar Pratyush
    Nilima Gangadhar Sakharkar
    Ashwini Gajanan Bhope
    Kanchan Tekram Sawarkar
    Vaibhav Santosh Nimbekar
    Future Journal of Pharmaceutical Sciences, 8
  • [33] Mass spectrometry reveals potential of β-lactams as SARS-CoV-2 Mpro inhibitors
    Malla, Tika R.
    Tumber, Anthony
    John, Tobias
    Brewitz, Lennart
    Strain-Damerell, Claire
    Owen, C. David
    Lukacik, Petra
    Chan, H. T. Henry
    Maheswaran, Pratheesh
    Salah, Eidarus
    Duarte, Fernanda
    Yang, Haitao
    Rao, Zihe
    Walsh, Martin A.
    Schofield, Christopher J.
    CHEMICAL COMMUNICATIONS, 2021, 57 (12) : 1430 - 1433
  • [34] Sofosbuvir may be a potential anti-sars-cov-2 rdrp drug
    Ibrahim M.N.
    Elfiky A.A.
    American Journal of Biochemistry and Biotechnology, 2021, 17 (02): : 205 - 207
  • [35] Natural products and phytochemicals as potential anti-SARS-CoV-2 drugs
    Merarchi, Myriam
    Dudha, Namrata
    Das, Bhudev C.
    Garg, Manoj
    PHYTOTHERAPY RESEARCH, 2021, 35 (10) : 5384 - 5396
  • [36] Computational Studies of Cannabis Derivatives as Potential Inhibitors of SARS-CoV-2 Mpro
    Mounadi, Nouh
    Nour, Hassan
    Daoui, Ossama
    Elkhattabi, Souad
    Errougui, Abdelkbir
    Talbi, Mohammed
    El Kouali, Mhammed
    Chtita, Samir
    CHEMISTRY AFRICA-A JOURNAL OF THE TUNISIAN CHEMICAL SOCIETY, 2024, 7 (05): : 2569 - 2580
  • [37] Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
    Katre, Soumya Gulab
    Asnani, Alpana Jagdish
    Pratyush, Kumar
    Sakharkar, Nilima Gangadhar
    Bhope, Ashwini Gajanan
    Sawarkar, Kanchan Tekram
    Nimbekar, Vaibhav Santosh
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 8 (01)
  • [38] In Silico Identification of Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro)
    Hernandez-Serda, Manuel Alejandro
    Vazquez-Valadez, Victor H.
    Aguirre-Vidal, Pablo
    Markarian, Nathan M.
    Medina-Franco, Jose L.
    Cardenas-Granados, Luis Alfonso
    Alarcon-Lopez, Aldo Yoshio
    Martinez-Soriano, Pablo A.
    Velazquez-Sanchez, Ana Maria
    Falfan-Valencia, Rodolfo E.
    Angeles, Enrique
    Abrahamyan, Levon
    PATHOGENS, 2024, 13 (10):
  • [39] Synthesis and Biological Evaluation of Umifenovir Analogues as Anti-SARS-CoV-2 Agents
    Tanaka, Hiroaki
    Miyagi, Seiya
    Yoshida, Yusuke
    Lamb, Justin Steven
    Chick, Christian Nanga
    Luhata, Lokadi Pierre
    Shibata, Mizuho
    Tanaka, Eri
    Suzuki, Yumiko
    Usuki, Toyonobu
    CHEMISTRYSELECT, 2022, 7 (30):
  • [40] Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
    Neogi, Ujjwal
    Hill, Kyle J.
    Ambikan, Anoop T.
    Heng, Xiao
    Quinn, Thomas P.
    Byrareddy, Siddappa N.
    Soennerborg, Anders
    Sarafianos, Stefan G.
    Singh, Kamal
    PATHOGENS, 2020, 9 (05):
12345